QURE (STOCKS)
uniQure N.V.
$17.910000
+2.530000 (+16.45%)
Prev close: $15.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Matthew C. Kapusta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,102.71M
- Employees
- 209
- P/E (TTM)
- -5.15
- P/B (TTM)
- 4.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.64 | $-0.97 | +0.3251 | +33.69% |
|
Sep 2025 (Q3)
|
$-1.38 | $-0.92 | -0.4624 | -50.39% |
|
Jun 2025 (Q2)
|
$-0.69 | $-0.91 | +0.2221 | +24.35% |
|
Mar 2025 (Q1)
|
$-0.82 | $-1.03 | +0.2056 | +20.05% |
Financial Statements
| Revenues | $16.10M |
| Benefits Costs and Expenses | $209.44M |
| Cost Of Revenue | $1.69M |
| Costs And Expenses | $207.82M |
| Gross Profit | $14.41M |
| Operating Expenses | $199.76M |
| Selling, General, and Administrative Expenses | $65.46M |
| Depreciation and Amortization | $14.76M |
| Research and Development | $140.67M |
| Operating Income/Loss | -$185.35M |
| Other Operating Income/Expenses | $628.00K |
| Income/Loss From Continuing Operations After Tax | -$198.97M |
| Income/Loss From Continuing Operations Before Tax | -$193.34M |
| Income Tax Expense/Benefit | $5.63M |
| Income Tax Expense/Benefit, Current | $4.04M |
| Income Tax Expense/Benefit, Deferred | $1.59M |
| Net Income/Loss | -$198.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$198.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$198.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.46 |
| Diluted Earnings Per Share | -$3.46 |
| Basic Average Shares | 57,502,068 |
| Diluted Average Shares | 57,502,068 |
| Assets | $824.91M |
| Current Assets | $655.99M |
| Prepaid Expenses | $20.51M |
| Other Current Assets | $635.48M |
| Noncurrent Assets | $168.92M |
| Fixed Assets | $13.80M |
| Intangible Assets | $72.79M |
| Other Non-current Assets | $82.33M |
| Liabilities | $626.01M |
| Current Liabilities | $62.92M |
| Accounts Payable | $5.17M |
| Wages | $9.94M |
| Other Current Liabilities | $47.81M |
| Noncurrent Liabilities | $563.09M |
| Long-term Debt | $71.92M |
| Other Non-current Liabilities | $491.17M |
| Equity | $198.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $198.90M |
| Liabilities And Equity | $824.91M |
| Net Cash Flow From Operating Activities | -$177.96M |
| Net Cash Flow From Operating Activities, Continuing | -$177.96M |
| Net Cash Flow From Investing Activities | -$321.62M |
| Net Cash Flow From Investing Activities, Continuing | -$321.62M |
| Net Cash Flow From Financing Activities | $415.40M |
| Net Cash Flow From Financing Activities, Continuing | $415.40M |
| Exchange Gains/Losses | $5.66M |
| Net Cash Flow | -$78.53M |
| Net Cash Flow, Continuing | -$84.18M |
| Comprehensive Income/Loss | -$204.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$204.39M |
| Other Comprehensive Income/Loss | -$5.42M |
| Other Comprehensive Income/Loss Attributable To Parent | -$5.42M |